4,910 Shares in CVS Health Co. (NYSE:CVS) Purchased by OneAscent Financial Services LLC

OneAscent Financial Services LLC purchased a new stake in CVS Health Co. (NYSE:CVS) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 4,910 shares of the pharmacy operator’s stock, valued at approximately $309,000.

Several other large investors also recently made changes to their positions in the business. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the third quarter valued at approximately $25,000. Livelsberger Financial Advisory bought a new position in shares of CVS Health in the third quarter valued at $31,000. Reston Wealth Management LLC acquired a new stake in shares of CVS Health during the 3rd quarter valued at $32,000. First Community Trust NA grew its holdings in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health during the third quarter worth $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS stock opened at $55.82 on Wednesday. The firm has a 50 day moving average of $59.18 and a two-hundred day moving average of $58.60. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The company has a market capitalization of $70.24 billion, a price-to-earnings ratio of 14.17, a P/E/G ratio of 0.92 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the prior year, the company posted $2.21 earnings per share. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities analysts anticipate that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a $0.665 dividend. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.77%. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CVS shares. Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Evercore ISI raised their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Finally, UBS Group increased their target price on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $72.78.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.